Correlation Between Compugen and Adverum Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Compugen and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compugen and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Compugen and Adverum Biotechnologies, you can compare the effects of market volatilities on Compugen and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compugen with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compugen and Adverum Biotechnologies.

Diversification Opportunities for Compugen and Adverum Biotechnologies

-0.21

Correlation Coefficient

Compugen  Adverum Biotechnologies

Very good diversification

The 3 months correlation between Compugen and Adverum is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Compugen and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and Compugen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compugen are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of Compugen i.e., Compugen and Adverum Biotechnologies go up and down completely randomly.

Pair Corralation between Compugen and Adverum Biotechnologies

Given the investment horizon of 90 days Compugen is expected to generate 0.69 times more return on investment than Adverum Biotechnologies. However, Compugen is 1.46 times less risky than Adverum Biotechnologies. It trades about 0.01 of its potential returns per unit of risk. Adverum Biotechnologies is currently generating about -0.07 per unit of risk. If you would invest  148.00  in Compugen on May 2, 2025 and sell it today you would lose (4.00) from holding Compugen or give up 2.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Compugen  vs.  Adverum Biotechnologies

Compugen

Risk-Adjusted Performance

Very Weak

Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Compugen is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Adverum Biotechnologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adverum Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Compugen and Adverum Biotechnologies

The main advantage of trading using opposite Compugen and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compugen position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.

The idea behind Compugen and Adverum Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.